Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000004

Director sold 42,461 shares at $25.09 ($1,065,206)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaye Edward M. MD · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-03 Sale : show line 1 in the form 10b5-1 −42,461 $25.09 $1,065,206 49,124 D
Open-market sales · 42,461 sh · avg $25.09 · $1,065,206
Loading xslF345X05/form4-10072025_081055.xml…